U.S., Europe, and Asia Pacific Molecular Diagnostics Market
- 2026 年市場規模
- USD 11,960 Mn
- 2033 年預估規模
- USD 24,230 Mn
- 年複合成長率 CAGR
- 10.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Product Type (Reagents, Kits & Instruments), By Technology (PCR-based, NGS-based), By Application (Genetic Testing, Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), By End Users (Hospitals, Clinics, Ambulatory Surgery Centers), By Geography (U.S., Europe, Asia Pacific)
報告摘要
For detecting the disturbance between specific sequences in DNA or RNA, molecular diagnostics tests are used, which may be associated with disease. The other factors which lead to various diseases are disturbance between single nucleotide polymorphism, rearrangements, insertions, and others. Infectious diseases, virology, oncology and STDs are the diseases that are diagnosed by utilizing molecular diagnostic test.
Molecular diagnostics has the capacity of detecting specific disease which access in supplying accurate medicine to patients. On research and development of precision medicine various government economies are focused on diagnostic tests, which is estimated to drive the growth of the U.S., Europe, and Asia Pacific molecular diagnostics market over the forecast period.
Market Dynamics
Increasing applications of biomarkers, new product launches by market players with increasing government initiatives, increasing demand for molecular diagnostic tests, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the U.S., Europe, and Asia Pacific molecular diagnostics market.
The growth of molecular diagnostics market is expected to increase the research and development for identification of biomarkers which leads to new molecular diagnostic tests development. For instance, in February 2018, authorization to Banyan Biomarkers, Inc., a biotech company, was given by the U.S. FDA (Food and Drug Administration) for traumatic brain injury, for first diagnostic blood test.
Key features of the study
• This report provides in-depth analysis of the U.S., Europe, and Asia Pacific molecular diagnostics market provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S., Europe, and Asia Pacific molecular diagnostics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories, Hologic, Inc., Grifols, S.A., Qiagen N.V., F.Hoffmann-La Roche Ltd., Siemens Healthineers, Becton, Dickinson and Company, Beckmann Coulter, Inc., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S., Europe, and Asia Pacific molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S., Europe, and Asia Pacific molecular diagnostics market
Market Segmentation
• By Product Type Insights (Revenue, USD Mn, 2020 - 2033)
o Reagents
o Kits & Instruments
• By Technology Insights (Revenue, USD Mn, 2020 - 2033)
o PCR-based
o NGS-based
• By Application Insights (Revenue, USD Mn, 2020 - 2033)
o Genetic Testing
o Oncology
o Microbiology
o STDs
o Blood Screening
o Virology
o Tissue Typing
o Prenatal Diagnosis
o Others
• By End Users Insights (Revenue, USD Mn, 2020 - 2033)
o Hospitals
o Clinics
o Ambulatory Surgery Centers
• By Region Insights (Revenue, USD Mn, 2020 - 2033)
o U.S.
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
• Key Players
o Abbott Laboratories
o Hologic, Inc.
o Grifols, S.A.
o Qiagen N.V.
o F.Hoffmann-La Roche Ltd.
o Siemens Healthineers
o Becton, Dickinson and Company
o Beckmann Coulter, Inc.
o Bio-Rad Laboratories
o Thermo Fisher Scientific Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Technology
Market Snippet, By Application
Market Snippet, By End Users
Market Snippet, By Country
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Product approval and launches
o Merges and Acquisitions
o Key development
o Regulatory Scenario
o Reimbursement Scenario
o Brand Analysis
o PEST Analysis
o Pricing Analysis
o Technology Advancement
4. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Product Type, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Reagents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Kits & Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
5. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Technology, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o PCR-based
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o NGS-based
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
6. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Application, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Genetic Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Microbiology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o STDs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Blood Screening
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Virology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Tissue Typing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Prenatal Diagnosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
7. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By End Users, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Ambulatory Surgery Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
8. U.S., Europe, and Asia Pacific Molecular Diagnostics Market, By Country, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2020 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2018–2028
o U.S.
Market Size and Forecast, By Product Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Technology, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2020 – 2033, (USD Mn)
Market Size and Forecast, By End Users, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o Europe
Market Size and Forecast, By Product Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Technology, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2020 – 2033, (USD Mn)
Market Size and Forecast, By End Users, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Product Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Technology, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Application, 2020 – 2033, (USD Mn)
Market Size and Forecast, By End Users, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Abbott Laboratories
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Hologic, Inc.
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Grifols, S.A.
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Qiagen N.V.,
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
F.Hoffmann-La Roche Ltd.,
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Siemens Healthineers
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Becton, Dickinson and Company
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Beckmann Coulter, Inc.
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Bio-Rad Laboratories
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
Thermo Fisher Scientific Inc.
o Company highlights
o Product Portfolio
o Key Highlights
o Financial performance
o Strategies
10. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療器材）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們